neurontin 400 mg/1 kapsula kapsula, tvrda
viatris bh d.o.o. - габапентин - kapsula, tvrda - 400 mg/1 kapsula - 1 kapsula sadrži: 400 mg gabapentina
tiramat 100 mg/1 tableta filmom obložena tableta
farmavita d.o.o. sarajevo - topiramat - filmom obložena tableta - 100 mg/1 tableta - 1 filmom obložena tableta sadrži: 100 mg topiramata
tiramat 25 mg/1 tableta filmom obložena tableta
farmavita d.o.o. sarajevo - topiramat - filmom obložena tableta - 25 mg/1 tableta - 1 filmom obložena tableta sadrži: 25 mg topiramata
tiramat 50 mg/1 tableta filmom obložena tableta
farmavita d.o.o. sarajevo - topiramat - filmom obložena tableta - 50 mg/1 tableta - 1 filmom obložena tableta sadrži: 50 mg topiramata
verion 0,5 mg/1 kapsula kapsula, meka
bosnalijek d.d. - dutasterid - kapsula, meka - 0,5 mg/1 kapsula - 1 kapsula, meka sadrži: 0,5 mg dutasterida
aliette flash
bayer ag - močive samodispergirajuće granule (wg) - fosetil-al (80 %)
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
sitagliptin accord
accord healthcare s.l.u. - sitagliptin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
verion 0,5 mg/1 kapsula kapsula, meka
bosnalijek d.d. - dutasterid - kapsula, meka - 0,5 mg/1 kapsula - 1 kapsula, meka sadrži: 0,5 mg dutasterida